Anixa Biosciences, Inc.
ANIX · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $1 | $2 | $1 |
| G&A Expenses | $1 | $2 | $2 | $2 |
| SG&A Expenses | $1 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $3 | $3 | $3 |
| Operating Income | -$2 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $0 | -$3 | -$3 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |
| EPS | -0.07 | -0.087 | -0.099 | 0.3 |
| % Growth | 19.2% | 12.4% | -133% | – |
| EPS Diluted | -0.07 | -0.087 | -0.1 | 0.3 |
| Weighted Avg Shares Out | 32 | 32 | 32 | 32 |
| Weighted Avg Shares Out Dil | 32 | 32 | 32 | 32 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |